Nanopharm (UK) is Discovery Tools (Healthcare) in United Kingdom that focus on development services business. Founded in 2002. They cover business area such as provider, tailor analytical and drug development service, a focus, orally inhaled and nasal drug product, material characterization, formulation development, inhaled biopharmaceutic, successful product development, material property, processing condition, pre-clinical development, clinical manufacturing.
2002
( 22 years old in 2024 )
Development Services
-
Cavendish House
Newport NP10 8FY
England, United Kingdom
Private
providertailor analytical and drug development servicea focusorally inhaled and nasal drug productmaterial characterizationformulation developmentinhaled biopharmaceuticsuccessful product developmentmaterial propertyprocessing conditionpre-clinical developmentclinical manufacturing
* We use standard office opening hours in near Nanopharm (UK)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Nanopharm (UK) is Discovery Tools (Healthcare) business from United Kingdom that founded in 2002 (22 years old in 2024), Nanopharm (UK) business is focusing on Development Services.
Nanopharm (UK) headquarter office and corporate office address is located in Cavendish House Newport NP10 8FY England, United Kingdom.
Nanopharm (UK) was founded in United Kingdom.
In 2024, Nanopharm (UK) is currently focus on development services sector.
Above is snippet of Google Trends for "development services" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Nanopharm (UK), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.